This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Feb;35(4):471-472.

doi: 10.1200/JCO.2016.70.7745. Epub 2016 Nov 21.

Reply to C.G. Drake

Mark N Stein¹, Thomas L Jang¹

Affiliations

PMID: 27870573
DOI: 10.1200/JCO.2016.70.7745

Comment

Reply to C.G. Drake

Mark N Stein et al. J Clin Oncol. 2017 Feb.

. 2017 Feb;35(4):471-472.

doi: 10.1200/JCO.2016.70.7745. Epub 2016 Nov 21.

Authors

Mark N Stein¹, Thomas L Jang¹

Affiliation

¹ Mark N. Stein and Thomas L. Jang, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

PMID: 27870573
DOI: 10.1200/JCO.2016.70.7745

No abstract available

PubMed Disclaimer

Comment on

Striving Toward a Cure for Prostate Cancer.
Stein MN, Jang TL. Stein MN, et al. J Clin Oncol. 2016 Jun 20;34(18):2075-8. doi: 10.1200/JCO.2015.66.3146. Epub 2016 Mar 28. J Clin Oncol. 2016. PMID: 27022121 No abstract available.
Risk Associated With High-Dose Bicalutamide.
Drake CG. Drake CG. J Clin Oncol. 2017 Feb;35(4):471. doi: 10.1200/JCO.2016.69.4299. Epub 2016 Nov 21. J Clin Oncol. 2017. PMID: 27870564 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations